Association between the Use of Dipeptidyl Peptidase 4 Inhibitors and the Risk of Dementia among Patients with Type 2 Diabetes in Taiwan

Study Objectives: Diabetes mellitus per se and its related therapy have been frequently associated with an increased risk of developing dementia. However, studies that explored the risk of dementia from the use of the novel oral antidiabetic medication dipeptidyl peptidase 4 inhibitor (DPP-4i) have...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Kuan-Chan, Chung, Chi-Hsiang, Lu, Chieh-Hua, Tzeng, Nian-Sheng, Lee, Chien-Hsing, Su, Sheng-Chiang, Kuo, Feng-Chih, Liu, Jhih-Syuan, Hsieh, Chang-Hsun, Chien, Wu-Chien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141309/
https://www.ncbi.nlm.nih.gov/pubmed/32121372
http://dx.doi.org/10.3390/jcm9030660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141309/
https://www.ncbi.nlm.nih.gov/pubmed/32121372
http://dx.doi.org/10.3390/jcm9030660

Ejemplares similares